Search

everythinglearnresearchcommunity

for

Search:↓

Understanding the Y chromosome is key to male health, aging, and developing diagnostic tools.

Lifestyle changes like a healthy diet, exercise, and proper sleep can help manage PCOD.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Spironolactone can reduce hair growth in women with hirsutism.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Cimetidine did not reduce hair growth in women with hirsutism.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride reduces hair growth better, but spironolactone has more side effects.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

All three treatments reduce hirsutism, but spironolactone works best long-term.